DIALYSIS · Loading…
DIALYSIS · CCN 132532
DaVita Syringa Home Training ID
BOISE, ID 83706
DialysisProfitDaVita
$2.8M
TOTAL REVENUE
18.9%
OPERATING MARGIN
N/A
STAR RATING
9
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL
Cost report financials (FY2024)
- Net patient revenue
- $2.8M
- Total costs
- $2.3M
- Operating income (rev − costs)
- $525K
- Operating margin
- 18.9%
- Total charges
- $2.2M
- Total treatments
- 7,157
- Dialysis stations
- —
Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.
02 — QUALITY MEASURES
9 quality measures
| Measure | Score | Denominator | Period |
|---|---|---|---|
Standardized ED Visits Within 30 Days of Hospital Discharge DFC_ED30 | 1.07 | 19 | — |
First Year Standardized Kidney Transplant Waitlist Ratio DFC_FYSWR | 1.19 | 27 | — |
Healthcare Worker COVID-19 Vaccination Adherence DFC_HCP_VACC | 0 | — | — |
Patient Hospitalization Rate DFC_HOSPITALIZATION_RATE | 107.4 | 55 | — |
Patient Survival (Mortality Rate) DFC_MORTALITY_RATE | 24.4 | 219 | — |
Percentage of Prevalent Patients Waitlisted for Kidney Transplant DFC_PPPW | 14.5 | 50 | — |
Patient Hospital Readmission Rate DFC_READMISSION_RATE | 19.2 | 28 | — |
Standardized ED Visits Ratio DFC_SEDR | 0.81 | 22 | — |
Patient Transfusion Rate DFC_TRANSFUSION_RATE | 18.3 | 20 | — |